McLeod HL - Search Results

1

Prospect for immune checkpoint blockade: dynamic and comprehensive monitorings pave the way.

Wang W, Liu J, He Y, McLeod HL. Wang W, et al. Among authors: mcleod hl. Pharmacogenomics. 2017 Aug;18(13):1299-1304. doi: 10.2217/pgs-2017-0053. Epub 2017 Jul 26. Pharmacogenomics. 2017. PMID: 28745931 Review.

2

Copy number variants in pharmacogenetic genes.

He Y, Hoskins JM, McLeod HL. He Y, et al. Among authors: mcleod hl. Trends Mol Med. 2011 May;17(5):244-51. doi: 10.1016/j.molmed.2011.01.007. Epub 2011 Mar 8. Trends Mol Med. 2011. PMID: 21388883 Free PMC article. Review.

3

Ready when you are: easing into preemptive pharmacogenetics.

He YJ, McLeod HL. He YJ, et al. Among authors: mcleod hl. Clin Pharmacol Ther. 2012 Oct;92(4):412-4. doi: 10.1038/clpt.2012.144. Clin Pharmacol Ther. 2012. PMID: 22992667 Review.

4

Cumulative genetic risk predicts platinum/taxane-induced neurotoxicity.

McWhinney-Glass S, Winham SJ, Hertz DL, Yen Revollo J, Paul J, He Y, Brown R, Motsinger-Reif AA, McLeod HL; Scottish Gynaecological Clinical Trials Group. McWhinney-Glass S, et al. Among authors: mcleod hl. Clin Cancer Res. 2013 Oct 15;19(20):5769-76. doi: 10.1158/1078-0432.CCR-13-0774. Epub 2013 Aug 20. Clin Cancer Res. 2013. PMID: 23963862 Free PMC article.

5

The prognostic value of altered eIF3a and its association with p27 in non-small cell lung cancers.

Shen J, Yin JY, Li XP, Liu ZQ, Wang Y, Chen J, Qu J, Xu XJ, McLeod HL, He YJ, Xia K, Jia YW, Zhou HH. Shen J, et al. Among authors: mcleod hl. PLoS One. 2014 Apr 30;9(4):e96008. doi: 10.1371/journal.pone.0096008. eCollection 2014. PLoS One. 2014. PMID: 24789280 Free PMC article.

6

Epigenetic perspectives on cancer chemotherapy response.

Liu MZ, McLeod HL, He FZ, Chen XP, Zhou HH, Shu Y, Zhang W. Liu MZ, et al. Among authors: mcleod hl. Pharmacogenomics. 2014 Apr;15(5):699-715. doi: 10.2217/pgs.14.41. Pharmacogenomics. 2014. PMID: 24798726 Review.

7

Accuracy of SNPs to predict risk of HLA alleles associated with drug-induced hypersensitivity events across racial groups.

He Y, Hoskins JM, Clark S, Campbell NH, Wagner K, Motsinger-Reif AA, McLeod HL. He Y, et al. Among authors: mcleod hl. Pharmacogenomics. 2015 Jul;16(8):817-24. doi: 10.2217/pgs.15.41. Epub 2015 Jun 17. Pharmacogenomics. 2015. PMID: 26083016

8

Carboplatin/taxane-induced gastrointestinal toxicity: a pharmacogenomics study on the SCOTROC1 trial.

He YJ, Winham SJ, Hoskins JM, Glass S, Paul J, Brown R, Motsinger-Reif A, McLeod HL. He YJ, et al. Among authors: mcleod hl. Pharmacogenomics J. 2016 Jun;16(3):243-8. doi: 10.1038/tpj.2015.52. Epub 2015 Jul 21. Pharmacogenomics J. 2016. PMID: 26194361 Clinical Trial.

9

Evaluating the role of admixture in cancer therapy via in vitro drug response and multivariate genome-wide associations.

Jack J, Havener TM, McLeod HL, Motsinger-Reif AA, Foster M. Jack J, et al. Among authors: mcleod hl. Pharmacogenomics. 2015;16(13):1451-63. doi: 10.2217/PGS.15.85. Epub 2015 Aug 28. Pharmacogenomics. 2015. PMID: 26314407 Free PMC article.

10

Comparison of genetic variation in drug ADME-related genes in Thais with Caucasian, African and Asian HapMap populations.

Jittikoon J, Mahasirimongkol S, Charoenyingwattana A, Chaikledkaew U, Tragulpiankit P, Mangmool S, Inunchot W, Somboonyosdes C, Wichukchinda N, Sawanpanyalert P, He Y, McLeod HL, Chantratita W. Jittikoon J, et al. Among authors: mcleod hl. J Hum Genet. 2016 Feb;61(2):119-27. doi: 10.1038/jhg.2015.115. Epub 2015 Oct 1. J Hum Genet. 2016. PMID: 26423926

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

587 results

Search Page